News
Explore how LC-MS technologies are transforming forensic and clinical toxicology by enabling comprehensive compound detection ...
Explore cutting-edge methods for detecting alcohol biomarkers and drugs of abuse using alternative sample matrices.
About PYRUKYND® (mitapivat) U.S. INDICATION PYRUKYND is a pyruvate kinase activator indicated for the treatment of hemolytic anemia in adults with pyruvate kinase (PK) deficiency.
The teams were able to replicate the results of less than half of the tested experiments 1. That rate is in keeping ... the country’s science, the study’s authors say.
Software engineering: To create machine learning systems, you’ll need an understanding of software engineering. Machine learning algorithms and frameworks: Algorithms and frameworks are tools that you ...
Nightview Capital discusses automation, AI, electrification and trends shaping the future. Click here to read their latest ...
Q1 2025 pharma services revenue of $2.1 million, at 62% gross margin; Three of the top 10 U.S. transplant centers expected to participate in clinical trial; Ten globally leading t ...
Imperial Brands Plc, parent company of Greensboro's ITG Brands Plc, announced Wednesday that Stefan Bomhard plans to retire as chief executive on Oct. 1. Bomhard, who has served as chief executive ...
The U.S. Food and Drug Administration (FDA) approved Kamada's application to manufacture CYTOGAM in May 2023. During the year ...
Welcome to the Conference Call hosted by Daré Bioscience to review the company's First Quarter 2025 Financial Results and to provide the Business Update. This call is being recorded. My name is Gayle ...
NaV1.9 is a voltage-gated sodium channel selectively expressed in peripheral sensory neurones that plays a key role in pain signalling.
Q1 2025 pharma services revenue of $2.1 million, at 62% gross marginThree of the top 10 U.S. transplant centers expected to participate in clinical trialTen globally leading transplant hospitals are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results